In fact, our analyses are supported by recent studies in mice transgenic for both the human amyloid precursor protein (APP) gene, as well as CETP, showing accelerated AD progression concomitant with a 22% increase of cholesterol content in brain [28]. The gene discussed is APP; the disease is Alzheimer disease.